India's GDP 11 times more than Bangladesh in PPP terms

In PPP terms, India's per capita GDP in 2020 is estimated by IMF at $6,284 as compared to $5,139 for Bangladesh

PTI

October 15, 2020 / 09:48 IST

India's Gross Domestic Product (GDP) in terms of purchasing power parity (PPP) was 11 times more than that of Bangladesh in 2019, government sources said on October 14 as they played down IMF projections of India slipping below the neighbouring nation on per capita GDP this year.

Earlier in the day in a tweet, Congress leader Rahul Gandhi took a dig at the government over IMF growth projections showing Bangladesh closing in on India in terms of per capita GDP this year and described it as a "solid achievement" of six years of BJP's "hate-filled cultural nationalism".

The government sources, on their part, emphasised that under the Modi government, the per capita GDP has increased from Rs 83,091 in 2014-15 to Rs 108,620 in 2019-20, representing an increase of 30.7 per cent.

“In 2019, India's GDP in PPP terms was 11 times more than that of Bangladesh while population was eight times more. In PPP terms, India's per capita GDP in 2020 is estimated by IMF at $6,284 as compared to $5,139 for Bangladesh,” according to the sources.

Follow our LIVE Updates on the coronavirus pandemic here

COVID-19 Vaccine

Frequently Asked Questions

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

Show